These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22958443)

  • 1. Explaining the increase in coronary heart disease mortality in Syria between 1996 and 2006.
    Rastam S; Al Ali R; Maziak W; Mzayek F; Fouad FM; O'Flaherty M; Capewell S
    BMC Public Health; 2012 Sep; 12():754. PubMed ID: 22958443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Explaining the decline in coronary heart disease mortality rates in the Slovak Republic between 1993-2008.
    Psota M; Bandosz P; Gonçalvesová E; Avdičová M; Bucek Pšenková M; Studenčan M; Pekarčíková J; Capewell S; O'Flaherty M
    PLoS One; 2018; 13(1):e0190090. PubMed ID: 29320517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Explaining the increment in coronary heart disease mortality in Mexico between 2000 and 2012.
    Arroyo-Quiroz C; O'Flaherty M; Guzman-Castillo M; Capewell S; Chuquiure-Valenzuela E; Jerjes-Sanchez C; Barrientos-Gutierrez T
    PLoS One; 2020; 15(12):e0242930. PubMed ID: 33270684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999.
    Critchley J; Liu J; Zhao D; Wei W; Capewell S
    Circulation; 2004 Sep; 110(10):1236-44. PubMed ID: 15337690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting cardiovascular mortality trends in Eastern Mediterranean populations: Contributions from risk factor changes and treatments.
    Critchley J; Capewell S; O'Flaherty M; Abu-Rmeileh N; Rastam S; Saidi O; Sözmen K; Shoaibi A; Husseini A; Fouad F; Ben Mansour N; Aissi W; Ben Romdhane H; Unal B; Bandosz P; Bennett K; Dherani M; Al Ali R; Maziak W; Arık H; Gerçeklioğlu G; Altun DU; Şimşek H; Doganay S; Demiral Y; Aslan Ö; Unwin N; Phillimore P; ; ; Achour N; Aissi W; Allani R; Arfa C; Abu-Kteish H; Abu-Rmeileh N; Al Ali R; Altun D; Ahmad B; Arık H; Aslan Ö; Beltaifa L; Ben Mansour N; Bennett K; Ben Romdhane H; Ben Salah N; Collins M; Critchley J; Capewell S; Dherani M; Demiral Y; Doganay S; Elias M; Ergör G; Fadhil I; Fouad F; Gerçeklioğlu G; Ghandour R; Göğen S; Husseini A; Jaber S; Kalaca S; Khatib R; Khatib R; Koudsie S; Kilic B; Lassoued O; Mason H; Maziak W; Mayaleh MA; Mikki N; Moukeh G; Flaherty MO; Phillimore P; Rastam S; Roglic G; Saidi O; Saatli G; Satman I; Shoaibi A; Şimşek H; Soulaiman N; Sözmen K; Tlili F; Unal B; Unwin N; Yardim N; Zaman S
    Int J Cardiol; 2016 Apr; 208():150-61. PubMed ID: 26878275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008.
    Unal B; Sözmen K; Arık H; Gerçeklioğlu G; Altun DU; Şimşek H; Doganay S; Demiral Y; Aslan Ö; Bennett K; O'Flaherty M; Capewell S; Critchley J
    BMC Public Health; 2013 Dec; 13():1135. PubMed ID: 24308515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007.
    Bruthans J; Cífková R; Lánská V; O'Flaherty M; Critchley JA; Holub J; Janský P; Zvárová J; Capewell S
    Eur J Prev Cardiol; 2014 Jul; 21(7):829-39. PubMed ID: 23180867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005.
    Wijeysundera HC; Machado M; Farahati F; Wang X; Witteman W; van der Velde G; Tu JV; Lee DS; Goodman SG; Petrella R; O'Flaherty M; Krahn M; Capewell S
    JAMA; 2010 May; 303(18):1841-7. PubMed ID: 20460623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000.
    Palmieri L; Bennett K; Giampaoli S; Capewell S
    Am J Public Health; 2010 Apr; 100(4):684-92. PubMed ID: 19608958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Explaining the decline in coronary heart disease mortality rates in Japan: Contributions of changes in risk factors and evidence-based treatments between 1980 and 2012.
    Ogata S; Nishimura K; Guzman-Castillo M; Sumita Y; Nakai M; Nakao YM; Nishi N; Noguchi T; Sekikawa A; Saito Y; Watanabe T; Kobayashi Y; Okamura T; Ogawa H; Yasuda S; Miyamoto Y; Capewell S; O'Flaherty M
    Int J Cardiol; 2019 Sep; 291():183-188. PubMed ID: 30826193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention.
    Unal B; Critchley JA; Capewell S
    BMJ; 2005 Sep; 331(7517):614. PubMed ID: 16107431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyzing recent coronary heart disease mortality trends in Tunisia between 1997 and 2009.
    Saidi O; Ben Mansour N; O'Flaherty M; Capewell S; Critchley JA; Ben Romdhane H
    PLoS One; 2013; 8(5):e63202. PubMed ID: 23658808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.
    Capewell S; Morrison CE; McMurray JJ
    Heart; 1999 Apr; 81(4):380-6. PubMed ID: 10092564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley JA; Capewell S
    BMC Public Health; 2007 Jun; 7():117. PubMed ID: 17584932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China.
    Moran A; Zhao D; Gu D; Coxson P; Chen CS; Cheng J; Liu J; He J; Goldman L
    BMC Public Health; 2008 Nov; 8():394. PubMed ID: 19036167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010.
    Cheng J; Zhao D; Zeng Z; Critchley JA; Liu J; Wang W; Sun J; Capewell S
    BMC Public Health; 2009 Jan; 9():30. PubMed ID: 19159492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse risk factor trends limit gains in coronary heart disease mortality in Barbados: 1990-2012.
    Sobers NP; Unwin N; Samuels TA; Capewell S; O'Flaherty M; Critchley JA
    PLoS One; 2019; 14(4):e0215392. PubMed ID: 30995272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explaining the Decline in Coronary Heart Disease Mortality in the Netherlands between 1997 and 2007.
    Koopman C; Vaartjes I; van Dis I; Verschuren WM; Engelfriet P; Heintjes EM; Blokstra A; Deeg DJ; Visser M; Bots ML; O'Flaherty M; Capewell S
    PLoS One; 2016; 11(12):e0166139. PubMed ID: 27906998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000.
    Bennett K; Kabir Z; Unal B; Shelley E; Critchley J; Perry I; Feely J; Capewell S
    J Epidemiol Community Health; 2006 Apr; 60(4):322-7. PubMed ID: 16537349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley J; Feely J; Capewell S
    QJM; 2006 Aug; 99(8):523-30. PubMed ID: 16861717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.